| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | 1.72e-05 | 479 | 95 | 11 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EZR TTBK2 EPS8 XIRP1 DST MYH13 BRCA1 MAP2 MAP4 PSG9 MYO1H RDX MYO1B CCDC88B MSN | 2.05e-04 | 1099 | 95 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.51e-04 | 118 | 95 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.14e-04 | 28 | 95 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 8.04e-06 | 9 | 96 | 3 | GO:2000643 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 1.15e-05 | 10 | 96 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 1.15e-05 | 10 | 96 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule binding | 2.14e-05 | 2 | 96 | 2 | GO:1904527 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.68e-05 | 257 | 96 | 8 | GO:0007163 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 3.43e-05 | 14 | 96 | 3 | GO:1905668 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 4.27e-05 | 15 | 96 | 3 | GO:1905666 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 5.24e-05 | 16 | 96 | 3 | GO:1902946 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 1.05e-04 | 20 | 96 | 3 | GO:2000641 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 1.11e-04 | 162 | 96 | 6 | GO:0032388 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.80e-04 | 177 | 96 | 6 | GO:0030010 | |
| GeneOntologyCellularComponent | microvillus | 1.48e-06 | 123 | 95 | 7 | GO:0005902 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.95e-06 | 278 | 95 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | actin cytoskeleton | EZR FLOT2 XIRP1 DST MYH13 MAP2 MYO1H ITSN1 SIPA1L3 RDX MYO1B TEK | 1.16e-05 | 576 | 95 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | cell-cell junction | EZR FLOT2 XIRP1 DST PSG9 SIPA1L3 PVR NFASC RDX FLRT1 TEK MSN | 1.50e-05 | 591 | 95 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | focal adhesion | 2.65e-05 | 431 | 95 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | uropod | 3.19e-05 | 14 | 95 | 3 | GO:0001931 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.35e-05 | 443 | 95 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | cell trailing edge | 3.98e-05 | 15 | 95 | 3 | GO:0031254 | |
| GeneOntologyCellularComponent | adherens junction | 5.19e-05 | 212 | 95 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | cell tip | 5.90e-05 | 17 | 95 | 3 | GO:0051286 | |
| GeneOntologyCellularComponent | Schwann cell microvillus | 6.11e-05 | 3 | 95 | 2 | GO:0097454 | |
| GeneOntologyCellularComponent | cell pole | 9.80e-05 | 20 | 95 | 3 | GO:0060187 | |
| GeneOntologyCellularComponent | filopodium | 2.47e-04 | 123 | 95 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | apical part of cell | 3.58e-04 | 592 | 95 | 10 | GO:0045177 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.44e-04 | 223 | 95 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | brush border | 6.52e-04 | 152 | 95 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.44e-03 | 107 | 95 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.44e-03 | 107 | 95 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | anchoring junction | EZR FLOT2 XIRP1 DST PSG9 SIPA1L3 PVR NFASC RDX FLRT1 TEK MSN | 1.54e-03 | 976 | 95 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | apical plasma membrane | 1.69e-03 | 487 | 95 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | sarcolemma | 1.76e-03 | 190 | 95 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | cell leading edge | 2.00e-03 | 500 | 95 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | actomyosin | 2.01e-03 | 117 | 95 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.07e-03 | 118 | 95 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | myosin complex | 2.46e-03 | 59 | 95 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | lateral element | 3.32e-03 | 19 | 95 | 2 | GO:0000800 | |
| Domain | ERM_C_dom | 4.92e-07 | 4 | 94 | 3 | IPR011259 | |
| Domain | ERM | 4.92e-07 | 4 | 94 | 3 | PF00769 | |
| Domain | ERM | 4.92e-07 | 4 | 94 | 3 | IPR011174 | |
| Domain | Moesin_tail | 4.26e-06 | 7 | 94 | 3 | IPR008954 | |
| Domain | TAU_MAP_2 | 7.49e-05 | 3 | 94 | 2 | PS51491 | |
| Domain | Tubulin-binding | 7.49e-05 | 3 | 94 | 2 | PF00418 | |
| Domain | MAP_tubulin-bd_rpt | 7.49e-05 | 3 | 94 | 2 | IPR001084 | |
| Domain | TAU_MAP_1 | 7.49e-05 | 3 | 94 | 2 | PS00229 | |
| Domain | MAP2/MAP4/Tau | 7.49e-05 | 3 | 94 | 2 | IPR027324 | |
| Domain | Ez/rad/moesin-like | 1.54e-04 | 21 | 94 | 3 | IPR000798 | |
| Domain | FERM_CS | 2.31e-04 | 24 | 94 | 3 | IPR019747 | |
| Domain | FERM_C | 2.95e-04 | 26 | 94 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 3.31e-04 | 27 | 94 | 3 | IPR018980 | |
| Domain | FERM_C | 3.31e-04 | 27 | 94 | 3 | SM01196 | |
| Domain | - | 3.71e-04 | 6 | 94 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 3.71e-04 | 6 | 94 | 2 | PF00930 | |
| Domain | Peptidase_S9B_N | 3.71e-04 | 6 | 94 | 2 | IPR002469 | |
| Domain | FERM_N | 6.04e-04 | 33 | 94 | 3 | IPR018979 | |
| Domain | FERM_N | 6.04e-04 | 33 | 94 | 3 | PF09379 | |
| Domain | Peptidase_S9 | 1.34e-03 | 11 | 94 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 1.34e-03 | 11 | 94 | 2 | IPR001375 | |
| Domain | FERM_M | 1.60e-03 | 46 | 94 | 3 | PF00373 | |
| Domain | - | 1.92e-03 | 49 | 94 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 1.92e-03 | 49 | 94 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.92e-03 | 49 | 94 | 3 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.04e-03 | 50 | 94 | 3 | IPR014352 | |
| Domain | FERM_1 | 2.04e-03 | 50 | 94 | 3 | PS00660 | |
| Domain | FERM_2 | 2.04e-03 | 50 | 94 | 3 | PS00661 | |
| Domain | FERM_3 | 2.04e-03 | 50 | 94 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.04e-03 | 50 | 94 | 3 | IPR019749 | |
| Domain | B41 | 2.04e-03 | 50 | 94 | 3 | SM00295 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.19e-03 | 14 | 94 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.19e-03 | 14 | 94 | 2 | IPR024743 | |
| Domain | MT | 2.19e-03 | 14 | 94 | 2 | PF12777 | |
| Domain | AAA_8 | 2.19e-03 | 14 | 94 | 2 | PF12780 | |
| Domain | DHC_fam | 2.52e-03 | 15 | 94 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 2.52e-03 | 15 | 94 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.52e-03 | 15 | 94 | 2 | IPR004273 | |
| Domain | PH_dom-like | 5.71e-03 | 426 | 94 | 7 | IPR011993 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 2.50e-05 | 12 | 70 | 3 | M45558 | |
| Pubmed | A novel role for BRCA1 in regulating breast cancer cell spreading and motility. | 2.72e-10 | 5 | 96 | 4 | 21282464 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 8479753 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 18261459 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 21659656 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 19064715 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 21864676 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 14613898 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 2.04e-08 | 3 | 96 | 3 | 26555866 | |
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 2.04e-08 | 3 | 96 | 3 | 23703860 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 2.04e-08 | 3 | 96 | 3 | 16889625 | |
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 2.04e-08 | 3 | 96 | 3 | 21837648 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 2.04e-08 | 3 | 96 | 3 | 19124745 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 2.04e-08 | 3 | 96 | 3 | 22132106 | |
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 2.04e-08 | 3 | 96 | 3 | 19321616 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 29906485 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 2.04e-08 | 3 | 96 | 3 | 31843195 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 21278069 | ||
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 2.04e-08 | 3 | 96 | 3 | 15149851 | |
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 2.04e-08 | 3 | 96 | 3 | 21352885 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 1429901 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 2.04e-08 | 3 | 96 | 3 | 32098334 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 2.04e-08 | 3 | 96 | 3 | 12360288 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 2.04e-08 | 3 | 96 | 3 | 28889652 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 2.04e-08 | 3 | 96 | 3 | 23116763 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 21451358 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 20679347 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 2.04e-08 | 3 | 96 | 3 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 2.04e-08 | 3 | 96 | 3 | 25286001 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 17977945 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 15252013 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 32160548 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 12734202 | ||
| Pubmed | Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. | 2.65e-08 | 12 | 96 | 4 | 18579745 | |
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 8.14e-08 | 4 | 96 | 3 | 27793041 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 15096511 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 17237445 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 15178693 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 20660156 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 19129194 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 31018575 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 24760896 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 8.14e-08 | 4 | 96 | 3 | 20855527 | |
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 8.14e-08 | 4 | 96 | 3 | 12070130 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 19890007 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 28302370 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 22685202 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 21289089 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 8.14e-08 | 4 | 96 | 3 | 21148287 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 18941185 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 15818415 | ||
| Pubmed | Proteomic profiling in pancreatic cancer with and without lymph node metastasis. | 8.14e-08 | 4 | 96 | 3 | 19152423 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 19255442 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 9890997 | ||
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 9464455 | ||
| Pubmed | Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. | 2.03e-07 | 5 | 96 | 3 | 23326330 | |
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 19830727 | ||
| Pubmed | A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells. | 2.03e-07 | 5 | 96 | 3 | 23063725 | |
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 21278261 | ||
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 22891241 | ||
| Pubmed | The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. | 2.03e-07 | 5 | 96 | 3 | 10806479 | |
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 23019340 | ||
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 25575591 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 17515952 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 23229862 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 9472040 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 17349711 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 26209696 | ||
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 22291017 | ||
| Pubmed | MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. | 7.08e-07 | 7 | 96 | 3 | 23264465 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 8.44e-07 | 477 | 96 | 10 | 31300519 | |
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 24788249 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.24e-06 | 498 | 96 | 10 | 36634849 | |
| Pubmed | Finding the Unicorn, a New Mouse Model of Midfacial Clefting. | 1.69e-06 | 9 | 96 | 3 | 31940751 | |
| Pubmed | Radixin regulates cell migration and cell-cell adhesion through Rac1. | 1.69e-06 | 9 | 96 | 3 | 22467863 | |
| Pubmed | 4.40e-06 | 12 | 96 | 3 | 29361573 | ||
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 5.71e-06 | 13 | 96 | 3 | 24135232 | |
| Pubmed | Embryo-uterine interaction coordinates mouse embryogenesis during implantation. | 5.71e-06 | 13 | 96 | 3 | 37522872 | |
| Pubmed | Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. | 7.26e-06 | 14 | 96 | 3 | 27641493 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23519473 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33932609 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25299115 | ||
| Pubmed | Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. | 7.54e-06 | 2 | 96 | 2 | 26242871 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12111362 | ||
| Pubmed | Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. | 7.54e-06 | 2 | 96 | 2 | 22736146 | |
| Pubmed | Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology. | 7.54e-06 | 2 | 96 | 2 | 31382374 | |
| Pubmed | Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. | 7.54e-06 | 2 | 96 | 2 | 28624994 | |
| Pubmed | Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma. | 7.54e-06 | 2 | 96 | 2 | 27042764 | |
| Pubmed | Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. | 7.54e-06 | 2 | 96 | 2 | 12534281 | |
| Pubmed | E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. | 7.54e-06 | 2 | 96 | 2 | 12909625 | |
| Pubmed | Moesin: a member of the protein 4.1-talin-ezrin family of proteins. | 7.54e-06 | 2 | 96 | 2 | 1924289 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21711053 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9213396 | ||
| Pubmed | BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. | 7.54e-06 | 2 | 96 | 2 | 20075200 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 7579708 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 38458339 | ||
| Pubmed | Ezrin has properties to self-associate at the plasma membrane. | 7.54e-06 | 2 | 96 | 2 | 7844168 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12890753 | ||
| Pubmed | DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. | 7.54e-06 | 2 | 96 | 2 | 16700509 | |
| Pubmed | Emerging role for ERM proteins in cell adhesion and migration. | 7.54e-06 | 2 | 96 | 2 | 21343695 | |
| Interaction | RDX interactions | 1.10e-07 | 284 | 96 | 11 | int:RDX | |
| Interaction | MAPRE3 interactions | 1.43e-05 | 230 | 96 | 8 | int:MAPRE3 | |
| Cytoband | 15q15.2 | 5.09e-04 | 16 | 96 | 2 | 15q15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 1.50e-03 | 107 | 96 | 3 | chr11q22 | |
| Cytoband | 19p13.3 | 1.59e-03 | 237 | 96 | 4 | 19p13.3 | |
| Cytoband | 5q14.1 | 3.05e-03 | 39 | 96 | 2 | 5q14.1 | |
| GeneFamily | CD molecules|DASH family | 2.98e-04 | 7 | 69 | 2 | 1205 | |
| GeneFamily | Myosins, class I | 3.96e-04 | 8 | 69 | 2 | 1097 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.17e-04 | 50 | 69 | 3 | 1293 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 185 | 96 | 6 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.54e-06 | 190 | 96 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.36e-06 | 197 | 96 | 6 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.49e-06 | 198 | 96 | 6 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 161 | 96 | 5 | 16f77e7a5444d2f2b210362816cd7a07b9b42af6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 161 | 96 | 5 | f5821f551cf5c64c9f75cdb723492c87aac1ece0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 161 | 96 | 5 | 58a32a1033f379579697bda1bbf047a088e4a34f | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 162 | 96 | 5 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 162 | 96 | 5 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 162 | 96 | 5 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 169 | 96 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 170 | 96 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.36e-05 | 170 | 96 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 3.65e-05 | 173 | 96 | 5 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.76e-05 | 174 | 96 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.07e-05 | 177 | 96 | 5 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-05 | 177 | 96 | 5 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 179 | 96 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.77e-05 | 183 | 96 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-05 | 185 | 96 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 96 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 96 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 185 | 96 | 5 | 48de4d9fad55077732bf64eca4919103ecbc1512 | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 5.29e-05 | 187 | 96 | 5 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 189 | 96 | 5 | e90ba6f6d7ba0698d04d84278aa035c28803733e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.70e-05 | 190 | 96 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.70e-05 | 190 | 96 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.79e-05 | 97 | 96 | 4 | 489f5e12eb67b1850f1f2d7d4b229df1f4ceefe3 | |
| ToppCell | NS-control-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.85e-05 | 191 | 96 | 5 | 27f2151da2f41015a979499f274ab1284a36189f | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | control-Lymphoid-CTL|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.85e-05 | 191 | 96 | 5 | 8df23473e24cfa51c09986102ddd391ed0f0b9cc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 192 | 96 | 5 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.99e-05 | 192 | 96 | 5 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-05 | 195 | 96 | 5 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 6.45e-05 | 195 | 96 | 5 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 195 | 96 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 197 | 96 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 197 | 96 | 5 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-05 | 198 | 96 | 5 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | LAM-Endothelial-VasEndo-2|Endothelial / Condition, Lineage and Cell class | 6.93e-05 | 198 | 96 | 5 | 92bccaec01f1dbb17d5efcba30f7f800f674ca96 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-05 | 200 | 96 | 5 | 147ceed692655f4ed73b8a57b0b3224def1f3055 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 200 | 96 | 5 | cee07d9370656e1c428a7a9e9fbd175129901374 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 7.98e-05 | 204 | 96 | 5 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | Cerebellum-Neuronal-Excitatory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.70e-04 | 128 | 96 | 4 | c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 131 | 96 | 4 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.20e-04 | 137 | 96 | 4 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-04 | 142 | 96 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-04 | 143 | 96 | 4 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-04 | 143 | 96 | 4 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-04 | 144 | 96 | 4 | f5d0d0564fcbec8a5d87119e0807b619faa77b0f | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 2.88e-04 | 147 | 96 | 4 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-04 | 149 | 96 | 4 | 32e0be7da42d26956683b21a1e7ae6915e4c16fb | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 3.03e-04 | 149 | 96 | 4 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-04 | 152 | 96 | 4 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 153 | 96 | 4 | 0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-04 | 63 | 96 | 3 | e1b68ef6123ad084ce602b09fd1ba394785797e5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-04 | 63 | 96 | 3 | 9bfd9ba1335a155ed9e56dd41dd3621b37d4234e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-04 | 63 | 96 | 3 | 9a90c761898618fc7e5e2984baa1021b74d4ac39 | |
| ToppCell | P28-Hematopoietic|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.43e-04 | 154 | 96 | 4 | 13980ae1957b05350c11171c9c118decfe998d3d | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 154 | 96 | 4 | e3a8a1e63ab345de62bd2e5e54342b00f04ae422 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-04 | 155 | 96 | 4 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 155 | 96 | 4 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 157 | 96 | 4 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | P28-Hematopoietic-Immune-immune_cell_unspecified|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.69e-04 | 157 | 96 | 4 | a70f93aff07b6b7a9efce33b12b024116648dc0a | |
| ToppCell | P28-Hematopoietic-Immune|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.69e-04 | 157 | 96 | 4 | b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-04 | 157 | 96 | 4 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 157 | 96 | 4 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-04 | 158 | 96 | 4 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 3.97e-04 | 160 | 96 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.55e-05 | 193 | 94 | 7 | 5351_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.60e-05 | 194 | 94 | 7 | 6833_DN | |
| Drug | 5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA | 1.60e-05 | 194 | 94 | 7 | 843_UP | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 1.66e-05 | 195 | 94 | 7 | 7058_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.66e-05 | 195 | 94 | 7 | 3409_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.66e-05 | 195 | 94 | 7 | 3191_DN | |
| Drug | UAMC00132 | 1.69e-05 | 2 | 94 | 2 | ctd:C524159 | |
| Drug | Ap 25 | 1.69e-05 | 2 | 94 | 2 | CID001010724 | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 3333_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 5461_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 5293_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 3448_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 2914_DN | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 4407_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 6782_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; HL60; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 6139_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 4477_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 7342_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 3277_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 6104_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 5295_UP | |
| Drug | topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 1.83e-05 | 198 | 94 | 7 | 915_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.95e-05 | 200 | 94 | 7 | 3405_DN | |
| Drug | AC1MHZPD | 2.40e-05 | 14 | 94 | 3 | CID003035635 | |
| Drug | SureCN3749646 | 5.05e-05 | 3 | 94 | 2 | CID011530920 | |
| Drug | phenyltetrazole | 5.05e-05 | 3 | 94 | 2 | CID000087425 | |
| Drug | SureCN3745540 | 5.05e-05 | 3 | 94 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 5.05e-05 | 3 | 94 | 2 | CID011974435 | |
| Drug | ABT-279 | 5.05e-05 | 3 | 94 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 39 | 5.05e-05 | 3 | 94 | 2 | CID011117606 | |
| Drug | Cyanopyrrolidine 38 | 5.05e-05 | 3 | 94 | 2 | CID010932707 | |
| Drug | SureCN3748611 | 5.05e-05 | 3 | 94 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 5.05e-05 | 3 | 94 | 2 | CID000193559 | |
| Drug | DMMP | 5.32e-05 | 18 | 94 | 3 | CID000012958 | |
| Drug | AC1Q5JYX | 7.36e-05 | 54 | 94 | 4 | CID000002020 | |
| Drug | glycylproline 4-nitroanilide | 1.01e-04 | 4 | 94 | 2 | ctd:C042892 | |
| Drug | N-DAM | 1.01e-04 | 4 | 94 | 2 | CID000152320 | |
| Drug | Ap 21 | 1.01e-04 | 4 | 94 | 2 | CID003030080 | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.38e-04 | 190 | 94 | 6 | 1334_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.46e-04 | 192 | 94 | 6 | 3469_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 2209_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 1.51e-04 | 193 | 94 | 6 | 1412_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 7232_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 7406_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A | 1.55e-04 | 194 | 94 | 6 | 1422_UP | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 4391_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 6741_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 3460_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 6958_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; HL60; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 1866_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 6821_DN | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 3210_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A | 1.59e-04 | 195 | 94 | 6 | 1946_UP | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 6510_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 5245_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 2311_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 1803_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 1524_DN | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 1857_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 6934_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 4415_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 5800_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2388_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 4844_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2687_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2506_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2236_UP | |
| Drug | Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 3541_DN | |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 3175_UP | |
| Drug | prodipine | 1.67e-04 | 5 | 94 | 2 | CID000065775 | |
| Drug | AC1L1H6N | 1.67e-04 | 5 | 94 | 2 | CID000003999 | |
| Drug | arginyl(PMC)-pyrrolidine-2-nitrile | 1.67e-04 | 5 | 94 | 2 | CID000487437 | |
| Drug | HEMA-EMA | 1.67e-04 | 5 | 94 | 2 | CID003082253 | |
| Drug | 1,2-dihydropyridine | 1.67e-04 | 5 | 94 | 2 | CID000407038 | |
| Drug | alanylproline-4-nitroanilide | 1.67e-04 | 5 | 94 | 2 | ctd:C083013 | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5335_UP | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 4777_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; HL60; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2172_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 3566_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; HL60; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2492_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5735_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1332_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 2080_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 5545_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 6196_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 3237_UP | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1316_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 7032_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1859_UP | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4808_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 7334_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 3434_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1503_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; HL60; HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1621_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.78e-04 | 199 | 94 | 6 | 900_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 6154_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 7020_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1325_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; HL60; HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1776_DN | |
| Drug | 5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.78e-04 | 199 | 94 | 6 | 920_DN | |
| Disease | Degenerative polyarthritis | 2.36e-04 | 93 | 95 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.36e-04 | 93 | 95 | 4 | C0086743 | |
| Disease | smoking status measurement, forced expiratory volume | 5.54e-04 | 11 | 95 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | peak insulin response measurement | 7.82e-04 | 13 | 95 | 2 | EFO_0008000 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 7.82e-04 | 13 | 95 | 2 | C1846647 | |
| Disease | periodontitis | 7.86e-04 | 223 | 95 | 5 | EFO_0000649 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.45e-03 | 69 | 95 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | psoriasis, type 2 diabetes mellitus | 1.85e-03 | 75 | 95 | 3 | EFO_0000676, MONDO_0005148 | |
| Disease | blood rubidium measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0021529 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKQQDPLVYKAIQQG | 596 | Q5FVE4 | |
| VRKVGAFVNKPINQV | 371 | O75143 | |
| SPTVEENNVVVKKQG | 31 | Q8IYS0 | |
| QAKNAQGQPAKVVTI | 326 | Q9HCK8 | |
| QGQPAKVVTIQLQVQ | 331 | Q9HCK8 | |
| QKPQQKSEGALEVQV | 696 | A6NC98 | |
| FPSIQVTGNKILVKQ | 11 | P10747 | |
| FLGKNVQDIKNVVLQ | 91 | Q14254 | |
| TEQGPQIDQKQFDKI | 351 | P47895 | |
| DQTVNPQNGFVRNKV | 621 | Q9UHI6 | |
| QEQIKKQKANIFVPS | 161 | Q6DHV5 | |
| QLGAQQEPVKKSIQE | 216 | O15519 | |
| QVIQKPGVVQRFVKF | 121 | O15131 | |
| KKDPATQQAFVFGQN | 251 | Q9H6Z4 | |
| QQGKVQKLEFPQEAN | 216 | Q14088 | |
| PNEVKVNQKQTVVAV | 211 | O75916 | |
| QPNTTGKQLFDQVVK | 21 | P35241 | |
| LTGQQVAIKKIPNAF | 76 | Q13164 | |
| KNKFIAAQGPKQETV | 201 | P23469 | |
| PQNFKLSQDDIKGIQ | 241 | P09237 | |
| GNVQIQNKKVDISKV | 1021 | P27816 | |
| VFQKEEIEPLQGKQQ | 5326 | Q03001 | |
| TFSKKENNQVPAVVA | 206 | P14543 | |
| PQNHEFKQAIGIKVN | 261 | Q6UXP7 | |
| QPNTTGKQLFDQVVK | 21 | P26038 | |
| AQSGSVPQFKKVVFQ | 1741 | P00451 | |
| QVKQQEQKYPQGVAS | 581 | Q9Y6M1 | |
| KQQQKAAFPSEGVVV | 41 | Q8N485 | |
| FEKATFIKVPQNQNG | 506 | P19338 | |
| KIKKVNVQVSFNPEN | 696 | Q460N5 | |
| NVQVSFNPENKQKGI | 701 | Q460N5 | |
| KVGKQIVENFSPNQT | 976 | O94856 | |
| GKNESNIKPVQTVNI | 911 | P38398 | |
| IPAKIQQVANIAQKF | 596 | Q8NCM8 | |
| QQQGKKPTAEQELYI | 526 | A4FU69 | |
| LSNFGAVPQQKKLQE | 131 | O75461 | |
| QAVSKQQVFSVQKGL | 291 | P41002 | |
| GPQVQLVNNSFKGIK | 646 | Q86TI2 | |
| GPQVQLVNNRFKGVK | 671 | Q6V1X1 | |
| FNKGQIINVLNKEDP | 1176 | Q15811 | |
| VTKLQQQVKTNGAGV | 261 | Q9NVF7 | |
| DFSPVVQQQKGKTIK | 221 | Q8NFQ5 | |
| VPNVGVNKNIFLKDQ | 241 | P53004 | |
| GPKQIQVAEAQNVLK | 2466 | Q0VDD8 | |
| VFNLQGKTPVSQKEE | 606 | Q9HBG7 | |
| KVSENEGFIPVNKNL | 551 | Q68CP4 | |
| KQESGVKIITQQVQP | 451 | Q7Z589 | |
| QKKFHVPRQNVPVIN | 706 | Q12929 | |
| QPNTTGKQLFDQVVK | 21 | P15311 | |
| NNAGIPQDLKTKVNV | 66 | Q9NZU1 | |
| VGFAQQTLKPQNRKV | 16 | P59796 | |
| AKLVSGVFKPNQQTV | 231 | Q9UNA4 | |
| GTKVQFNLQFTKPNA | 556 | Q6UVJ0 | |
| DQQVFIQKVVPITNK | 496 | Q9Y597 | |
| KNQVTQLKEQVPGFT | 21 | P11586 | |
| LFNKIRKQQQVPVAG | 196 | Q9H944 | |
| QLTVGVPKEIFQNEK | 56 | Q13423 | |
| QGLVKQLVGKNFNVV | 386 | Q8N807 | |
| VLAKPQNTAEVQKVQ | 141 | P15151 | |
| EFQQSFGKPTKQEIN | 131 | Q6ZR62 | |
| PRTVKKQIQFADQKQ | 116 | Q96HN2 | |
| FGPRNDKIKHVQNQV | 46 | O75379 | |
| KNLISAFQKPDQGIV | 81 | O60880 | |
| NTVKGKVPLQFSGQN | 126 | O43897 | |
| KVPLQFSGQNEKNRV | 131 | O43897 | |
| EQPQPVQRQFTNKEK | 586 | A6NKL6 | |
| QENVEKGQVQTKPTS | 1481 | O14513 | |
| KFQQSGQKLFIPQIT | 371 | Q00887 | |
| KKQVDTNTKNVFGQP | 1476 | O60292 | |
| QNPFSIQVIRKSNGK | 196 | P14410 | |
| NPFQIVLVKGNKLNT | 331 | P42338 | |
| KVGVKYTQQIIQGIQ | 246 | Q8TCS8 | |
| LKVGPKMVEVQNQQF | 126 | Q13326 | |
| KQIQQCQEGTAVKPA | 331 | Q14246 | |
| TKVNKVKPIGENNEN | 6 | Q9NQW8 | |
| VFPVQNINLVTQKKA | 126 | Q9Y271 | |
| LHIFQPKGKINNQVE | 151 | Q8N782 | |
| IQPQQILFTGNKTQV | 221 | P52655 | |
| QEQNKTKPEFNVGKV | 441 | A6NCW0 | |
| AIEKQLQQGIFPIKN | 141 | A4D1E1 | |
| QFPQLKKVIQFVCGN | 601 | Q8NDV3 | |
| VSQVQENGFVKKLEP | 11 | Q9HBF5 | |
| KEQQSNIAVFQGKKI | 411 | Q8NEF9 | |
| NVALKVESAQQPKQV | 46 | Q6IQ55 | |
| VKVGNEYVTKGQNVQ | 406 | Q9UKX3 | |
| QEQNKTKPEFNVGKV | 441 | Q7RTZ2 | |
| RSVQKSDQQNIKVPG | 581 | Q02763 | |
| QQKVFLGVLKPQHQA | 666 | O43548 | |
| DNIKYQPKGGQVQIV | 1681 | P11137 | |
| NNQDFIPFTKKRVGV | 121 | Q53FD0 | |
| NQKTVPNIFVNKVHV | 116 | Q86VQ6 | |
| QGTLQEKPIQINYKQ | 346 | Q9BXG8 | |
| VVEQNGSFQVKIPKN | 86 | Q8NDX6 | |
| QEVGGQTAVKNQAKV | 1601 | Q702N8 | |
| PVKNGKQFTKQNGET | 101 | P15822 | |
| VGIDSFQPSVQKQLK | 416 | Q9C0D4 | |
| QQKVPTIQQVHKFDI | 181 | Q8NB42 | |
| VCVKFIQGNQKNGSV | 1106 | O43795 | |
| KKENIVNVVQGSLQF | 981 | Q8N1T3 |